OpenVSafe by OpenVAERS
Search V-safe

6QE-35435-04104

4 vaccinations 4 coded responses 41 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
054 / VT
Registered
2021-03-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-25
    Registered in v-safe
  2. 2021-03-25
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-25
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Swelling · None
    Adult check-in
  4. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Nausea
    Adult check-in
  7. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-01
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-08
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-15
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-15
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches
    Adult check-in
  15. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-22
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-04-29
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-06
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-27
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-14
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-27
    Dose 3 — Pfizer-BioNTech
  29. 2021-11-03
    Survey response — day 7, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Swollen lymph nodes in my neck
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-11-10
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-11-17
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-11-24
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-12-01
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-12-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-01-26
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-04-27
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-10-17
    Dose 4 — Pfizer-BioNTech
  38. 2022-10-27
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-10-27
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  40. 2022-10-31
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-11-09
    Survey response — day 21, dose 4
    MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school
    Free text: Just a cold. Covid negative
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-11-14
    Survey response — day 28, dose 4
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: General cold
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-11-21
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  44. 2022-11-28
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  45. 2023-01-16
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  46. 2023-04-19
    Survey response — 6 months, dose 4
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-03-25Pfizer-BioNTech
22021-04-15Pfizer-BioNTech
32021-10-27Pfizer-BioNTech No
42022-10-17Pfizer-BioNTech No

Free text

Release 10 — day 7, dose 3

2021-11-03

Systemic reaction (other): Swollen lymph nodes in my neck

Release 12 — day 21, dose 4

2022-11-09

Symptoms: Just a cold. Covid negative

Release 12 — day 28, dose 4

2022-11-14

Symptoms: General cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDSARS-CoV-2 test negative · · ✓
SROLymphadenopathy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…